Ajman, United Arab Emirates: Ajman Free Zone signed a Memorandum of Understanding with the Center for Preventive Medicine Ajman, part of Ajman Medical Zone, with the aim of providing distinctive and exceptional services to investors, companies’ employees and workers, in the Free Zone.
The two parties have agreed to exchange data and information that contributes to a smooth and rapid completion of transactions, as well as enhance cooperation in the field of new technologies and procedures to better serve AFZ's customers. The agreement also includes a commitment from the Center for Preventive Medicine Ajman to resolve customer complaints, in addition to granting AFZ customers priority when completing transactions.
This initiative is part of AFZ’s relentless pursuit to achieve the highest levels of service for all members under the umbrella of the Free Zone, from investors, companies’ employee to workers.
Her Excellency Fatma Salem, Acting General Manager of Ajman Free Zone, said: “In our efforts to feature the highest facilitation of businesses with Ajman Free Zone, we continuously seek to establish fruitful relations with investors and other parties within the UAE which will result in ease of services and further enable the set-up of new businesses.”
Director of Ajman Medical District, His Excellency Hamad Taryam Al Shamsi, said: “We were delighted to sign the Memorandum of Understanding with Ajman Free Zone as a way of contributing to the economic growth of the Emirate of Ajman. We will continue accelerating the process and linking to the system of the Federal Authority for Identity and Citizenship in addition to providing various packages for medical examination, including ordinary and urgent care.”
Ajman Free Zone strives to provide the best solutions, including fast and innovative business establishment and post-business support services provided through the website and other communication platforms.
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
